Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS)

CNY 5.13

(0.2%)

Operating Income Summary of Henan Taloph Pharmaceutical Stock Co.,Ltd

  • Henan Taloph Pharmaceutical Stock Co.,Ltd's latest annual operating income in 2023 was 44.16 Million CNY , up 208.35% from previous year.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd's latest quarterly operating income in 2024 Q3 was 2.82 Million CNY , down -84.7% from previous quarter.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd reported an annual operating income of 27.46 Million CNY in 2022, down -79.0% from previous year.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd reported an annual operating income of 130.77 Million CNY in 2021, up 9.03% from previous year.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd reported a quarterly operating income of 2.82 Million CNY for 2024 Q3, down -84.7% from previous quarter.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd reported a quarterly operating income of 16.89 Million CNY for 2024 Q1, down -76.12% from previous quarter.

Annual Operating Income Chart of Henan Taloph Pharmaceutical Stock Co.,Ltd (2023 - 1996)

Historical Annual Operating Income of Henan Taloph Pharmaceutical Stock Co.,Ltd (2023 - 1996)

Year Operating Income Operating Income Growth
2023 44.16 Million CNY 208.35%
2022 27.46 Million CNY -79.0%
2021 130.77 Million CNY 9.03%
2020 119.93 Million CNY -14.06%
2019 139.55 Million CNY 223.38%
2018 -113.11 Million CNY -617.49%
2017 21.85 Million CNY 197.14%
2016 7.35 Million CNY 185.96%
2015 -8.55 Million CNY -113.33%
2014 64.2 Million CNY 0.93%
2013 63.61 Million CNY 79.54%
2012 35.43 Million CNY 149.72%
2011 14.18 Million CNY -47.98%
2010 27.27 Million CNY -13.05%
2009 31.36 Million CNY 68.03%
2008 18.66 Million CNY -23.81%
2007 24.5 Million CNY 60.99%
2006 15.21 Million CNY -22.53%
2005 19.64 Million CNY 1.57%
2004 19.34 Million CNY 155.24%
2003 7.57 Million CNY -50.09%
2002 15.18 Million CNY -54.69%
2001 33.5 Million CNY -26.33%
2000 45.48 Million CNY -0.36%
1999 45.64 Million CNY 15.27%
1998 39.6 Million CNY 6.59%
1997 37.15 Million CNY 152.0%
1996 14.74 Million CNY 0.0%

Peer Operating Income Comparison of Henan Taloph Pharmaceutical Stock Co.,Ltd

Name Operating Income Operating Income Difference
China Animal Husbandry Industry Co., Ltd. 402.76 Million CNY 89.034%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 132.68 Million CNY 66.713%
Yabao Pharmaceutical Group Co., Ltd 226.33 Million CNY 80.486%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 461.93 Million CNY 90.439%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 169.4 Million CNY 73.929%
Kangmei Pharmaceutical Co., Ltd. 86.66 Million CNY 49.038%
Tasly Pharmaceutical Group Co., Ltd 1.22 Billion CNY 96.403%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 563.79 Million CNY 92.166%
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.25 Billion CNY 98.644%
Shandong Lukang Pharmaceutical Co.,Ltd. 277.16 Million CNY 84.065%
North China Pharmaceutical Company Ltd. 540.51 Million CNY 91.829%
Zhejiang Shengda Bio-Pharm Co., Ltd. -45.67 Million CNY 196.695%
Zhejiang Starry Pharmaceutical Co.,Ltd. 138.93 Million CNY 68.211%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 473.24 Million CNY 90.667%
Shandong Buchang Pharmaceuticals Co., Ltd. 436.01 Million CNY 89.871%
Dali Pharmaceuticalco.,Ltd -17.03 Million CNY 359.265%
Guobang Pharma Ltd. 702.26 Million CNY 93.711%
ChengDu ShengNuo Biotec Co.,Ltd. 81.1 Million CNY 45.541%
Changchun BCHT Biotechnology Co. 559.29 Million CNY 92.103%
Shanghai Haoyuan Chemexpress Co., Ltd. 128.32 Million CNY 65.583%
Zhejiang Huahai Pharmaceutical Co., Ltd. 1.36 Billion CNY 96.759%
Harbin Pharmaceutical Group Co., Ltd. 659.62 Million CNY 93.304%
Zhejiang Medicine Co., Ltd. 380.15 Million CNY 88.382%
HPGC Renmintongtai Pharmaceutical Corporation 411.84 Million CNY 89.276%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 1.09 Billion CNY 95.974%
Lionco Pharmaceutical Group Co.,Ltd. -148.98 Million CNY 129.646%
Humanwell Healthcare (Group) Co.,Ltd. 3.44 Billion CNY 98.719%
Ginwa Enterprise (Group) Inc. -1.69 Million CNY 2705.747%
KPC Pharmaceuticals, Inc. 568.49 Million CNY 92.231%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 22.03 Million CNY -100.405%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 249.11 Million CNY 82.271%
Ningbo Menovo Pharmaceutical Co., Ltd. 18.74 Million CNY -135.58%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.17 Billion CNY 96.244%
Nanjing Well Pharmaceutical Group Co.,Ltd. 121.77 Million CNY 63.731%
Henan Lingrui Pharmaceutical Co., Ltd. 656.3 Million CNY 93.27%
Joincare Pharmaceutical Group Industry Co.,Ltd. 3.5 Billion CNY 98.74%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 1.51 Billion CNY 97.085%
Chongqing Taiji Industry(Group) Co.,Ltd 1.17 Billion CNY 96.235%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 5.12 Billion CNY 99.138%
China National Medicines Corporation Ltd. 2.94 Billion CNY 98.5%
Shenzhen Chipscreen Biosciences Co., Ltd. 97.07 Million CNY 54.501%
Guizhou Yibai Pharmaceutical Co., Ltd. 145.51 Million CNY 69.648%
Zhongzhu Healthcare Holding Co.,Ltd -135.23 Million CNY 132.659%
Beijing Tongrentang Co., Ltd 3.08 Billion CNY 98.568%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 97.08 Million CNY 54.51%
Jianmin Pharmaceutical Group Co.,Ltd. 573.86 Million CNY 92.304%
Tibet Weixinkang Medicine Co., Ltd. 174.96 Million CNY 74.757%
CanSino Biologics Inc. -1.93 Billion CNY 102.281%
Zhejiang Hisun Pharmaceutical Co., Ltd. 89.44 Million CNY 50.62%
Shanghai Jiaoda Onlly Co.,Ltd -25.57 Million CNY 272.693%
Jiang Zhong Pharmaceutical Co.,Ltd 894.11 Million CNY 95.06%
Mayinglong Pharmaceutical Group Co., LTD. 536.62 Million CNY 91.77%
Cisen Pharmaceutical Co., Ltd. 592.57 Million CNY 92.547%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 173.9 Million CNY 74.604%
Hunan Warrant Pharmaceutical Co.,Ltd 237.11 Million CNY 81.373%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 3.3 Billion CNY 98.665%
Hunan Fangsheng Pharmaceutical Co., Ltd. 196.44 Million CNY 77.517%
Shaanxi Kanghui Pharmaceutical Co., Ltd. -61.8 Million CNY 171.464%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -331.9 Million CNY 113.307%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 194.16 Million CNY 77.253%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.08 Billion CNY 95.917%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.45 Million CNY 77.403%
Tibet Rhodiola Pharmaceutical Holding Co. 899.09 Million CNY 95.088%
Sichuan Huiyu Pharmaceutical Co., Ltd. 124.36 Million CNY 64.487%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 174.77 Million CNY 74.729%